PortfoliosLab logoPortfoliosLab logo
EOSE vs. CRSP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

EOSE vs. CRSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eos Energy Enterprises Inc (EOSE) and CRISPR Therapeutics AG (CRSP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EOSE achieves a -17.80% return, which is significantly lower than CRSP's -0.80% return.


EOSE

1D
5.02%
1M
46.05%
YTD
-17.80%
6M
-26.29%
1Y
126.99%
3Y*
57.09%
5Y*
-13.16%
10Y*

CRSP

1D
-4.00%
1M
0.76%
YTD
-0.80%
6M
0.85%
1Y
40.78%
3Y*
-7.16%
5Y*
-13.88%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

EOSE vs. CRSP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
EOSE
Eos Energy Enterprises Inc
-17.80%135.80%345.87%-26.35%-80.32%-63.92%114.85%
CRSP
CRISPR Therapeutics AG
-0.80%33.23%-37.12%54.00%-46.36%-50.51%135.74%

Correlation

The correlation between EOSE and CRSP is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.32

Correlation (3Y)
Calculated over the trailing 3-year period

0.27

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Jun 4, 2020

0.29

Fundamentals

Market Cap

EOSE:

$5.13B

CRSP:

$5.00B

EPS

EOSE:

-$1.45

CRSP:

-$6.24

PS Ratio

EOSE:

19.27

CRSP:

1.15K

Total Revenue (TTM)

EOSE:

$160.71M

CRSP:

$4.10M

Gross Profit (TTM)

EOSE:

-$163.73M

CRSP:

-$171.17M

EBITDA (TTM)

EOSE:

-$858.77M

CRSP:

-$509.21M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EOSE vs. CRSP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EOSE
EOSE Risk / Return Rank: 7272
Overall Rank
EOSE Sharpe Ratio Rank: 7474
Sharpe Ratio Rank
EOSE Sortino Ratio Rank: 7676
Sortino Ratio Rank
EOSE Omega Ratio Rank: 7373
Omega Ratio Rank
EOSE Calmar Ratio Rank: 7070
Calmar Ratio Rank
EOSE Martin Ratio Rank: 6868
Martin Ratio Rank

CRSP
CRSP Risk / Return Rank: 6060
Overall Rank
CRSP Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
CRSP Sortino Ratio Rank: 6161
Sortino Ratio Rank
CRSP Omega Ratio Rank: 5858
Omega Ratio Rank
CRSP Calmar Ratio Rank: 6161
Calmar Ratio Rank
CRSP Martin Ratio Rank: 5858
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EOSE vs. CRSP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eos Energy Enterprises Inc (EOSE) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


EOSECRSPDifference

Sharpe ratio

Return per unit of total volatility

1.12

0.66

+0.46

Sortino ratio

Return per unit of downside risk

2.06

1.35

+0.71

Omega ratio

Gain probability vs. loss probability

1.25

1.16

+0.10

Calmar ratio

Return relative to maximum drawdown

1.64

1.03

+0.61

Martin ratio

Return relative to average drawdown

3.33

1.75

+1.59

EOSE vs. CRSP - Sharpe Ratio Comparison

The current EOSE Sharpe Ratio is 1.12, which is higher than the CRSP Sharpe Ratio of 0.66. The chart below compares the historical Sharpe Ratios of EOSE and CRSP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


EOSECRSPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.12

0.66

+0.46

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.11

-0.23

+0.12

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.00

0.23

-0.23

Drawdowns

EOSE vs. CRSP - Drawdown Comparison

The maximum EOSE drawdown since its inception was -97.88%, which is greater than CRSP's maximum drawdown of -85.11%. Use the drawdown chart below to compare losses from any high point for EOSE and CRSP.


Loading charts...

Drawdown Indicators


EOSECRSPDifference

Max Drawdown

Largest peak-to-trough decline

-97.88%

-85.11%

-12.77%

Max Drawdown (1Y)

Largest decline over 1 year

-77.10%

-42.25%

-34.85%

Max Drawdown (3Y)

Largest decline over 3 years

-87.18%

-64.91%

-22.27%

Max Drawdown (5Y)

Largest decline over 5 years

-96.94%

-80.68%

-16.26%

Current Drawdown

Current decline from peak

-69.05%

-75.23%

+6.18%

Average Drawdown

Average peak-to-trough decline

-72.39%

-49.16%

-23.23%

Ulcer Index

Depth and duration of drawdowns from previous peaks

37.96%

24.84%

+13.12%

Volatility

EOSE vs. CRSP - Volatility Comparison

Eos Energy Enterprises Inc (EOSE) has a higher volatility of 33.77% compared to CRISPR Therapeutics AG (CRSP) at 15.39%. This indicates that EOSE's price experiences larger fluctuations and is considered to be riskier than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EOSECRSPDifference

Volatility (1M)

Calculated over the trailing 1-month period

33.77%

15.39%

+18.38%

Volatility (6M)

Calculated over the trailing 6-month period

91.83%

42.57%

+49.26%

Volatility (1Y)

Calculated over the trailing 1-year period

113.81%

61.70%

+52.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

116.89%

60.49%

+56.40%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

112.93%

64.29%

+48.64%

Dividends

EOSE vs. CRSP - Dividend Comparison

Neither EOSE nor CRSP has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

EOSE vs. CRSP - Financials Comparison

This section allows you to compare key financial metrics between Eos Energy Enterprises Inc and CRISPR Therapeutics AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B20222023202420252026
56.96M
1.46M
(EOSE) Total Revenue
(CRSP) Total Revenue
Values in USD except per share items

Frequently Asked Questions


EOSE and CRSP have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

EOSE has higher volatility (33.77%) compared to CRSP (15.39%). In terms of maximum drawdown, EOSE dropped -97.88% vs CRSP's -85.11%.

EOSE currently has the higher Sharpe Ratio (1.12 vs 0.66), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EOSE and CRSP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer